BioXcel Therapeutics, Inc.
DEXMEDETOMIDINE TREATMENT REGIMENS
Last updated:
Abstract:
Disclosed herein are methods of administering dexmedetomidine or a pharmaceutically acceptable salt thereof to a human subject. The disclosed methods are particularly suitable for the treatment of agitation, especially when associated with neurodegenerative and/or neuropsychiatric diseases or disorders such as dementia and delirium.
Status:
Application
Type:
Utility
Filling date:
4 Jan 2022
Issue date:
21 Jul 2022